VentriPoint Diagnostics (CVE:VPT) Shares Down 14.7% – Here’s Why

VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares traded down 14.7% on Tuesday . The company traded as low as C$0.15 and last traded at C$0.15. 266,015 shares were traded during trading, a decline of 10% from the average session volume of 294,436 shares. The stock had previously closed at C$0.17.

VentriPoint Diagnostics Stock Performance

The firm has a market capitalization of C$23.52 million, a price-to-earnings ratio of -4.48 and a beta of 0.39. The stock’s fifty day moving average is C$0.10 and its two-hundred day moving average is C$0.13. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56.

VentriPoint Diagnostics Company Profile

(Get Free Report)

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.

Read More

• Five stocks we like better than VentriPoint Diagnostics
• Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
• NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
• Consumer Staples Stocks, Explained
• Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
• Want to Profit on the Downtrend? Downtrends, Explained.
• U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave